Cargando…
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
BACKGROUND: Lithium is recommended as a first line treatment for bipolar disorders. However, only 30% of patients show an optimal outcome and variability in lithium response and tolerability is poorly understood. It remains difficult for clinicians to reliably predict which patients will benefit wit...
Ejemplares similares
-
Transcranial Direct Current Stimulation (tDCS): A Promising Treatment for Major Depressive Disorder?
por: Bennabi, Djamila, et al.
Publicado: (2018) -
S212. LONG-TERM CHANGES OF MIRNA30A FOLLOWING EXPOSURE TO PRENATAL STRESS: MODULATORY EFFECTS OF LURASIDONE TREATMENT DURING ADOLESCENCE
por: Cattaneo, Annamaria, et al.
Publicado: (2020) -
Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
por: Bennabi, Djamila, et al.
Publicado: (2019) -
Irritability Is Associated With Decreased Cortical Surface Area and Anxiety With Decreased Gyrification During Brain Development
por: Piguet, Camille, et al.
Publicado: (2021) -
Psychomotor Retardation in Depression: A Systematic Review of Diagnostic, Pathophysiologic, and Therapeutic Implications
por: Bennabi, Djamila, et al.
Publicado: (2013)